ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.00 (+0.50%)
Close on Nov 17, 2026Market cap $138.97MP/E –Yield –
ALX Oncology EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for ALX Oncology
ALX Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?